J
Julia C. Stingl
Researcher at RWTH Aachen University
Publications - 153
Citations - 7364
Julia C. Stingl is an academic researcher from RWTH Aachen University. The author has contributed to research in topics: Population & Pharmacogenomics. The author has an hindex of 33, co-authored 147 publications receiving 5682 citations. Previous affiliations of Julia C. Stingl include University of Bonn & Federal Institute for Drugs and Medical Devices.
Papers
More filters
Journal ArticleDOI
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Christoph Hiemke,Niels Bergemann,Hans-Willi Clement,Andreas Conca,Jürgen Deckert,Katharina Domschke,Gabriel Eckermann,Karin Egberts,Manfred Gerlach,Christine Greiner,Gerhard Gründer,E Haen,Ursula Havemann-Reinecke,Gudrun Hefner,Renate Helmer,Ger Janssen,Eveline Jaquenoud,Gerd Laux,Thomas Messer,Rainald Mössner,Matthias J. Müller,Michael Paulzen,Bruno Pfuhlmann,P. Riederer,Alois Saria,Bernd Schoppek,Georgios Schoretsanitis,Markus J. Schwarz,M. Silva Gracia,Benedikt Stegmann,Werner Steimer,Julia C. Stingl,Manfred Uhr,S. Ulrich,Stefan Unterecker,R. Waschgler,Gerald Zernig,Gabriele Zurek,Pierre Baumann +38 more
TL;DR: Following the new guidelines for therapeutic drug monitoring in psychiatry holds the potential to improve neuropsychopharmacotherapy, accelerate the recovery of many patients, and reduce health care costs.
Journal ArticleDOI
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Christoph Hiemke,Pierre Baumann,Niels Bergemann,Andreas Conca,Otto Dietmaier,Karin Egberts,Miriam Fric,Manfred Gerlach,Christine Greiner,Gerhard Gründer,E Haen,Ursula Havemann-Reinecke,E. Jaquenoud Sirot,H. Kirchherr,Gerd Laux,U. C. Lutz,Thomas Messer,Matthias J. Müller,Bruno Pfuhlmann,Bernhard Rambeck,P. Riederer,Bernd Schoppek,Julia C. Stingl,Manfred Uhr,S. Ulrich,R. Waschgler,Gerald Zernig +26 more
TL;DR: Following guidelines for TDM in psychiatry will help to improve the outcomes of psychopharmacotherapy of many patients especially in case of pharmacokinetic problems, and one should never forget that TDM is an interdisciplinary task that sometimes requires the respectful discussion of apparently discrepant data.
Journal ArticleDOI
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
JK Hicks,Jeffrey R. Bishop,Katrin Sangkuhl,Daniel J. Müller,Yuan Ji,SG Leckband,J. S. Leeder,Rebecca L. Graham,DL Chiulli,Adrián LLerena,Todd C. Skaar,Stuart A. Scott,Julia C. Stingl,Teri E. Klein,Kelly E. Caudle,Andrea Gaedigk +15 more
TL;DR: Evidence from the published literature supporting associations between CYP2D6 and CYC19 polymorphisms and SSRIs efficacy and safety is summarized and dosing recommendations for fluvoxamine, paroxetine, citalopram, escitaloprams, and sertraline based on CYP1C19 genotype are provided.
Journal Article
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011
Christoph Hiemke,Pierre Baumann,Niels Bergemann,Otto Dietmaier,Karin Egberts,Miriam Fric,Manfred Gerlach,C Greiner,Gerhard Gründer,E Haen,Ursula Havemann-Reinecke,E. Jaquenoud Sirot,H. Kirchherr,Gerd Laux,U. C. Lutz,Thomas Messer,Matthias J. Müller,Bruno Pfuhlmann,Bernhard Rambeck,P. Riederer,Bernd Schoppek,Julia C. Stingl,Manfred Uhr,S. Ulrich,R. Waschgler,Gerald Zernig,Andreas Conca +26 more
TL;DR: Following guidelines for TDM in psychiatry will help to improve the outcomes of psychopharmacotherapy of many patients especially in case of pharmacokinetic problems, and one should never forget that TDM is an interdisciplinary task that sometimes requires the respectful discussion of apparently discrepant data.
Journal ArticleDOI
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
J K Hicks,Katrin Sangkuhl,Jesse J. Swen,Vicki L. Ellingrod,Daniel J. Müller,K Shimoda,Jeffrey R. Bishop,Evan D. Kharasch,Todd C. Skaar,Andrea Gaedigk,Henry M. Dunnenberger,Teri E. Klein,Kelly E. Caudle,Julia C. Stingl +13 more
TL;DR: In this paper, an update to the 2012 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP 2C19 Genotypes and Dosing of Tricyclic Antidepressants is presented.